---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-035238"
form_type: "8-K"
ticker: "MTVA"
cik: "0001638287"
company_name: "MetaVia Inc."
filed_at: "2026-03-26T23:59:59+00:00"
generated_at: "2026-05-15T08:50:28.258007+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# MetaVia posts updated corporate presentation on IR website; full content not in excerpt

## Summary
- Updated corporate presentation posted to MetaVia's IR website on March 26, 2026.
- Presentation highlights company's strategy for transforming cardiometabolic diseases.
- No financial, clinical, or pipeline details available from the provided excerpt.

## SEC filing metadata
- accession: 0001104659-26-035238
- form_type: 8-K
- ticker: MTVA
- cik: 0001638287
- company_name: MetaVia Inc.
- filed_at: 2026-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638287/000110465926035238/0001104659-26-035238-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638287/000110465926035238/mtva-20260326x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-035238
- JSON: https://secwatch.observer/filing/0001104659-26-035238.json
- Plain text: https://secwatch.observer/filing/0001104659-26-035238.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.